机译:新型氟吲哚异喹啉非摄像头甲基氨基异素酶I抑制剂
NCI Dev Therapeut Branch Ctr Canc Res NIH Bldg 37 Room 5068 Bethesda MD 20892 USA;
NCI Dev Therapeut Branch Ctr Canc Res NIH Bldg 37 Room 5068 Bethesda MD 20892 USA;
NCI Dev Therapeut Branch Ctr Canc Res NIH Bldg 37 Room 5068 Bethesda MD 20892 USA;
Leidos Biomed Res Inc Lab Anim Sci Program Frederick Natl Lab Canc Res Frederick MD USA;
Leidos Biomed Res Inc Lab Anim Sci Program Frederick Natl Lab Canc Res Frederick MD USA;
NCI Clin Pharmacol Program Genitourinary Malignancy Branch Ctr Canc Res NIH Bethesda MD 20892;
NCI Clin Pharmacol Program Genitourinary Malignancy Branch Ctr Canc Res NIH Bethesda MD 20892;
Purdue Univ Coll Pharm Dept Med Chem &
Mol Pharmacol Lafayette IN USA;
Purdue Univ Coll Pharm Dept Med Chem &
Mol Pharmacol Lafayette IN USA;
Purdue Univ Coll Pharm Dept Med Chem &
Mol Pharmacol Lafayette IN USA;
NCI Dev Therapeut Branch Ctr Canc Res NIH Bldg 37 Room 5068 Bethesda MD 20892 USA;
机译:新型氟吲哚异喹啉非摄像头甲基氨基异素酶I抑制剂
机译:4-取代的ANTHRA的设计,合成和评价[2,1-C] [1,2,5]噻二唑-6,11-二酮衍生物作为新型非摄像头甲基异构酶I抑制剂
机译:非喜树碱拓扑异构酶I抑制剂的设计,合成及抗肿瘤活性
机译:(±)-2-甲氧基-6-庚二酸和相关的2-甲氧基化类似物的首先完全合成,作为Leishmania Topoisoomerase IB酶的有效抑制剂*
机译:拓扑异构酶II抑制剂在人细胞中诱导的染色体损伤研究
机译:新型氟茚异喹啉非喜树碱拓扑异构酶I抑制剂
机译:苯基吡唑并[1,5-a]喹唑啉-5(4H)-one:用于开发非喜树碱拓扑异构酶I(Top1)抑制剂的合适支架。